AlphaSimPlex Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$280K Buy
+3,983
New +$312K 2.83% 11
2022
Q1
Sell
-2,829
Closed -$241K 86
2021
Q4
$241K Sell
2,829
-5,106
-64% -$399K 0.41% 86
2021
Q3
$600K Buy
7,935
+1,981
+33% +$157K 0.5% 62
2021
Q2
$484K Hold
5,954
0.24% 161
2021
Q1
$469K Sell
5,954
-5,877
-50% -$461K 0.2% 193
2020
Q4
$1.01M Buy
11,831
+7,611
+180% +$629K 0.35% 111
2020
Q3
$326K Buy
+4,220
New +$322K 0.15% 240
2019
Q3
Sell
-8,231
Closed -$590K 209
2019
Q2
$590K Buy
8,231
+2,493
+43% +$177K 0.18% 177
2019
Q1
$393K Buy
+5,738
New +$371K 0.13% 205

Other funds holding CL

AlphaSimPlex Group's CL Position: Q3 2022 in Review

AlphaSimPlex Group opened a new position in Colgate-Palmolive (CL) in Q3 2022: 3,983 shares worth $280K. The stake represents 2.83% of the portfolio and ranks #11 among its holdings. This is a return to the name: AlphaSimPlex Group previously reported a position in CL as recently as Q4 2021.

AlphaSimPlex Group first reported a position in CL in Q1 2019 and has held it in 9 quarters since. The position peaked at $1.01M in Q4 2020. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • AlphaSimPlex Group held 3,983 shares of Colgate-Palmolive worth $280K as of Q3 2022.
  • Colgate-Palmolive was a new AlphaSimPlex Group position in Q3 2022.
  • Colgate-Palmolive made up 2.83% of AlphaSimPlex Group's portfolio in Q3 2022, its #11 holding.
  • AlphaSimPlex Group first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 9 quarters since.
  • AlphaSimPlex Group's Colgate-Palmolive position peaked at $1.01M in Q4 2020.
  • 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on AlphaSimPlex Group's 13F filing for Q3 2022, filed 8 Nov 2022.